Respiro Diagnostics

Respiro Diagnostics is a biotechnology company developing non-invasive molecular diagnostics for respiratory diseases, initially focusing on lung cancer.

Its investigational platform collects exhaled breath samples and analyses lung-derived molecular biomarkers, including nucleic acids and proteins, to support earlier disease detection. Samples are processed in a laboratory rather than through a point-of-care reader.

The company is advancing its breath-collection and molecular analysis technology towards clinical studies, with potential applications in cancer screening and research.